The R&D management at a major pharmaceutical company was interested in exploring the use of existing antidepressant compounds, based on competitors' studies, for the treatment of a specific condition. This assessment was to be a key indicator for future clinical development along with helping identify optimal investment and prioritization strategies to enhance their pipeline. Solutions:
The Knowledge Discovery Platform enabled the client to have access to the relevant section of the proprietary Rogers MIS database through an interactive platform that is updated daily with the latest meeting and abstract information< br /> The Rogers MIS clinical team customized a specific ontology for depression and anxiety, incorporating the client's business rules to ensure insightful drill-down analysis of the search results Client Payoff:
Provided the R&D division with a comprehensive, real-time database of preclinical and clinical activity for all competitors in depression, allowing for an assessment of all global presentations and publications regarding the use of antidepressants in the treatment of this condition (including all known SNRIs, SSRIs, and tricyclic drugs)
Identified trends of competing marketed and pipeline drugs, as well as trends in drug classes
Identified Key Opinion Leaders speaking about drugs and competitors, by venue and subject nature
Most queries were developed and launched -- and the analysis delivered -- in a single day
Client Scenario and Objectives:
Solutions:
Client Payoff:
)